Sponsor and Exhibitor Directory Back to WebApp

The 5th Summit of International Pancreas and Islet Transplant Association (IPITA), Harvard Stem Cell Institute (HSCI) and Breakthrough T1D (Formerly JDRF) extends its appreciation to the following sponsors for their support.

IPITA would like to acknowledge the 5th Summit Co-Sponsors:

PLATINUM

Harvard Stem Cell Institute (HSCI)

Stem cell science to benefit human health.

Contact info
+1 617 495-1000

Visit the website

Breakthrough T1D (Formerly JDRF)

Our name and look have changed, but our mission has not! We are executing an ambitious plan to drive cures, and our job won’t be done until everyone can take their diabetes devices off for good.

Matthew Whipple
Analyst, Research Strategy
+1 212 479-7635
This email address is being protected from spambots. You need JavaScript enabled to view it.

Visit the website

Vertex Pharmaceuticals Incorporated

Vertex aims to create transformative medicines for people with serious diseases. It invests in cutting-edge science and innovation, including small molecules and cell and genetic therapies, to potentially treat type 1 diabetes, sickle cell disease, cystic fibrosis and other serious diseases. Learn more at www.vrtx.com.

Medical Information
+ 1 617 341-6100
This email address is being protected from spambots. You need JavaScript enabled to view it.

Visit the website

SILVER

Regenerative Medical Solutions (RMS)

Description to come

Contact info

Visit the website

Novo Nordisk A/S

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 69,000 people in 80 countries and markets its products in around 170 countries.

Contact info
+45 4444-8888

Visit the website

BRONZE

Evotec

From inception to clinic within iPSC-based cell therapeutics: Evotec has built a unique, end-to-end enabling platform for development and manufacturing of off-the-shelf cell therapeutics, fully integrated under one roof.  In line with Evotec’s theme “Together for Medicines that Matter”, we are working with strategic partners to collaborate and co-develop our proprietary pipeline across cell types and disease areas.

Audrey Holtzinger
Vice President, iPSC Cell Therapy
+49 551 5055-8561
This email address is being protected from spambots. You need JavaScript enabled to view it.

Visit the website

Eledon Pharmaceuticals

Eledon Pharmaceuticals is a clinical stage biotechnology company developing tegoprubart, an anti-CD40L antibody. The central role of CD40L signaling in adaptive and innate immune cell activation positions it as an attractive target for immunomodulatory indications. The Company is conducting preclinical and clinical studies in kidney allograft transplantation, and xenotransplantation.

Steven Perrin
President & Chief Scientific Officer
+1 617 470-5576
This email address is being protected from spambots. You need JavaScript enabled to view it.

Visit the website